Role of SALL4 in hematopoiesis

被引:19
|
作者
Yang, Jianchang [2 ]
Liao, Wenbin [1 ]
Ma, Yupo [1 ]
机构
[1] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA
[2] Nevada Canc Inst, Div Lab Med, Las Vegas, NV USA
关键词
bone marrow transplantation; DNA methyltransferases; ex-vivo expansion; hematopoietic stem cell; Mi-2/NuRD complex; WNT SIGNALING PATHWAY; EMBRYONIC STEM-CELLS; SELF-RENEWAL; OKIHIRO-SYNDROME; DNA METHYLTRANSFERASE; STEM/PROGENITOR CELLS; LEUKEMIC-CELLS; REVEALS SALL4; GENE SALL4; PROLIFERATION;
D O I
10.1097/MOH.0b013e328353c684
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review Stem cell gene SALL4 has been well characterized for its essential role in developmental events as well as embryonic stem cell pluripotency maintenance. Several current reports now shed new light on its functions in regulating hematopoietic cell self-renewal and differentiation. In this review we attempt to summarize SALL4 roles for normal hematopoiesis, and how the knowledge obtained can be used to develop advanced cell therapies. Recent findings SALL4 may act as a critical controller to regulate the fate of hematopoietic cells. In normal bone marrow, SALL4 is selectively expressed in primitive hematopoietic precursors and rapidly downregulated following differentiation. Of particular interest, SALL4 isoforms are able to stimulate large scale ex-vivo expansion of hematopoietic stem/progenitor cells (HSCs/HPCs). The SALL4 expanded HSCs/HPCs retain multilineage repopulation and long-term engraftment activities, which are clinically meaningful. The stem cell self-renewal mediated by SALL4 is linked to epigenetic machinery. Summary The emerging knowledge about how SALL4 regulates HSC behavior may be used in the near future to develop advanced cell therapies, for example, through large-scale stem cell expansion ex vivo.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 50 条
  • [21] Sall4 is dispensable for mouse limb development
    Kawakami, Yasuhiko
    Itou, Junji
    Nishinakamura, Ryuich
    Kawakami, Hiroko
    DEVELOPMENTAL BIOLOGY, 2010, 344 (01) : 485 - 485
  • [22] SALL4 is a marker of the embryonal subtype of hepatoblastoma
    Gnemmi, Viviane
    Leteurtre, Emmanuelle
    Sudour-Bonnange, Helene
    Devisme, Louise
    Guettier, Catherine
    Buob, David
    Leroy, Xavier
    HISTOPATHOLOGY, 2013, 63 (03) : 425 - 428
  • [23] SALL4: An emerging cancer biomarker and target
    Zhang, Xu
    Yuan, Xiao
    Zhu, Wei
    Qian, Hui
    Xu, Wenrong
    CANCER LETTERS, 2015, 357 (01) : 55 - 62
  • [24] Dedifferentiation and the Role of Sall4 in Reprogramming and Patterning During Amphibian Limb Regeneration
    Neff, Anton W.
    King, Michael W.
    Mescher, Anthony L.
    DEVELOPMENTAL DYNAMICS, 2011, 240 (05) : 979 - 989
  • [25] The diagnostic and prognostic value of SALL4 in hepatoblastoma
    Zhou, Shengmei
    Venkatramani, Rajkumar
    Gomulia, Ellen
    Shillingford, Nick
    Wang, Larry
    HISTOPATHOLOGY, 2016, 69 (05) : 822 - 830
  • [26] TARGETING THE ONCOFETAL PROTEIN SALL4 IN CANCER
    Tenen, Daniel
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S39 - S39
  • [27] SALL4 is a new target in endometrial cancer
    A Li
    Y Jiao
    K J Yong
    F Wang
    C Gao
    B Yan
    S Srivastava
    G S D Lim
    P Tang
    H Yang
    D G Tenen
    L Chai
    Oncogene, 2015, 34 : 63 - 72
  • [28] Expression of sall4 in taste buds of zebrafish
    Jackson, Robyn
    Braubach, Oliver R.
    Bilkey, Jessica
    Zhang, Jing
    Akimenko, Marie-Andree
    Fine, Alan
    Croll, Roger P.
    Jonz, Michael G.
    DEVELOPMENTAL NEUROBIOLOGY, 2013, 73 (07) : 543 - 558
  • [29] SALL4 is a new target in endometrial cancer
    Li, A.
    Jiao, Y.
    Yong, K. J.
    Wang, F.
    Gao, C.
    Yan, B.
    Srivastava, S.
    Lim, G. S. D.
    Tang, P.
    Yang, H.
    Tenen, D. G.
    Chai, L.
    ONCOGENE, 2015, 34 (01) : 63 - 72
  • [30] SALL4: An Intriguing Therapeutic Target in Cancer Treatment
    Moein, Shiva
    Tenen, Daniel G.
    Amabile, Giovanni
    Chai, Li
    CELLS, 2022, 11 (16)